United States · Funded startup
8 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$58Mraised across 8 rounds since 2006, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $995K sold, first sale Jun 2014
No investor was named in the report.
Reported by sec.govSEC filing: $969K sold, first sale Jul 2013
No investor was named in the report.
Reported by fis.dowjones.comSEC filing: $4.5M sold, first sale Dec 2010
Reported by finsmes.comSEC filing: $11M sold, first sale Dec 2009
No investor was named in the report.
From a historical funding record
Reported by eyegatepharma.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
VentechInnoven PartnersNexus Medical Partners
Medicis FundsNatixis Private EquityMissing a round, or an investor who was in one? Tell us.
EyeGate Pharmaceuticals's investors include Ventech, Innoven Partners, Nexus Medical Partners, Medicis Funds and Natixis Private Equity.
EyeGate Pharmaceuticals has raised $58M across 8 rounds since 2006.
EyeGate Pharmaceuticals's most recent round was a Debt of $995K in Jul 2014.
EyeGate Pharmaceuticals's largest round on record is $23M (Series D), in Jan 2010.
EyeGate Pharmaceuticals's first round on record, in Nov 2006, was backed by Ventech and Innoven Partners.
EyeGate Pharmaceuticals's latest named round is a Debt, in Jul 2014.
EyeGate Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·